Report
Dave Nicoski ...
  • Ross LaDuke
EUR 85.33 For Business Accounts Only

Vermilion Macro Vision: Sector Synopsis

Market dynamics are almost exclusively bearish and our key “lines in the sand” on the major indexes are being violated amid the escalating Russia/Ukraine war. This includes 4257 on the S&P 500, $334 on the Nasdaq 100 (QQQ), and 33,250 on the Dow Jones Industrial Average, while the Russell 2000 (IWM) has been below the important $209 level since mid-January. As long as prices are below the aforementioned levels, we are bearish and expect more volatility and lower prices ahead. The head-and-shoulders pattern breakdown on the S&P 500 implies a measured move price target of 3695; whether it hits this level or lower is anyone's guess, though it does provide us with a potential roadmap of where the market could be headed.

We are watching for the following developments in order to give us confidence that the bottom is in: (1) We would like to see a washout in the form of a 90%+ downside volume day (or back-to-back 80%+ downside volume days), followed by a bullish breadth thrust in the form of a 90%+ upside volume day (or back-to-back 80%+ upside volume days). (2) Bullish price inflections on the major indexes. (3) An RS uptrend violation for Consumer Staples. Absent these requirements, we expect the market to get worse before it gets better.

We are making several Sector weighting changes, including upgrading Consumer Staples, Utilities, and Materials to overweight, while simultaneously downgrading Technology and Financials to market weight, and downgrading Consumer Discretionary to underweight.

While we wait for the broad market to bottom, there are several attractive areas in this market where we recommend hiding out. Our favorite areas of the market include Energy (E&P, oil services, coal), Materials (agricultural chemicals and metals/mining including steel, gold, silver, aluminum, copper, uranium, etc.), Manufacturing (aerospace/defense), Transportation (shipping), Consumer Staples, Utilities, and Health Care (pharmaceuticals, hospitals, and HMOs)
Provider
Vermilion Research
Vermilion Research

Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.

Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.

Analysts
Dave Nicoski

Ross LaDuke

Other Reports from Vermilion Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch